Thu, February 25, 2021
Wed, February 24, 2021
Tue, February 23, 2021
Mon, February 22, 2021
Sun, February 21, 2021
Fri, February 19, 2021
Thu, February 18, 2021
Wed, February 17, 2021

Tejas Savant Maintained (TXG) at Buy with Increased Target to $215 on, Feb 22nd, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-215-on-feb-22nd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Tejas Savant of Morgan Stanley, Maintained "10x Genomics, Inc." (TXG) at Buy with Increased Target from $145 to $215 on, Feb 22nd, 2021.

Tejas has made no other calls on TXG in the last 4 months.



There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 1 agrees with Tejas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Amit Hazan of "Goldman Sachs" Initiated at Hold and Held Target at $150 on, Wednesday, December 2nd, 2020


These are the ratings of the 3 analyists that currently disagree with Tejas


  • Doug Schenkel of "Cowen & Co." Maintained at Buy with Increased Target to $200 on, Thursday, February 18th, 2021
  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $240 on, Thursday, February 18th, 2021
  • Tycho Peterson of "JP Morgan" Maintained at Buy with Increased Target to $195 on, Thursday, February 18th, 2021

Publication Contributing Sources